Corning (GLW) Life Sciences and Emerging Growth Businesses — Segment net sales — Quarterly & Annual

Screener

Similar metrics at other companies

DDDiversified Industrials — Segment net sales

$875M+3.1%

DDHealthcare & Water Technologies — Segment net sales

$806M+5.6%

DCILife Sciences Segment — Net Sales

$83.5M+12.5%

MTRNLife sciences — Net Sales

$13.22M-5.9%

DHRLife Sciences — Sales

$1.88B+5.7%

BIOLife Science — Net Sales

$228.5M0.0%

Other financials

Income statement

Revenue$4.5B+16.6%

Gross profit$1.6B+17.0%

Operating income$698.0M+21.8%

Net income$559.0M+19.2%

EPS (diluted)$0.64+18.5%

Balance sheet

Cash & equivalents$2.5B+67.9%

Total debt$8.5B+12.0%

Total equity$12.6B+13.0%

Total assets$33.0B+14.6%

Cash flow

Operating cash flow$1.7B+143%

CapEx$422.0M+37.0%

Free cash flow$1.3B+224%

Valuation

Market cap$134.98B+146%

Enterprise value$140.99B+131%

P/E71×+6.3×

P/S8×+4.1×

Profitability

Gross margin36.4%+1.6pp

Operating margin15.3%+3.3pp

Net margin11.2%+5.2pp

FCF margin14.1%+5.7pp

Returns & leverage

Return on equity16.1%+8.2pp

Debt / equity0.7×0.0×

Current ratio1.8×+0.3×

Where this comes from

Reported directly by Corning in its filing.

Tagged under the XBRL concept glw:NetSalesOfReportableSegmentsAndAllOther.

The source filing: Corning’s 10-Q, filed July 29, 2026.

Filed: Jul 29, 2026, 12:22 PM EDT
Fiscal quarter: Q2 FY2026
Calendar quarter: Q2 2026
Accession: 0000024741-26-000255

Three months ended June 30, 2026	Optical Communications	Glass Innovations	Automotive	Solar	Total Reportable Segments	Life Sciences and Emerging Growth Businesses	Total
Segment net sales	$2,072	$1,463	$471	$438	$4,444	$294	$4,738
Less:
Research, development and engineering expenses (1)	92	92	36	3	223	27	250
Depreciation (2)	77	150	39	77	343	23	366
Other segment items (3)	1,338	774	292	363	2,767	271	3,038
Income tax provision (benefit) (4)	127	93	22	2	244	(6)	238
Segment net income (loss)	$438	$354	$82	$(7)	$867	$(21)	$846
Capital expenditures	$180	$123	$16	$92	$411	$9	$420

Item 1. Financial Statements

FAQ

What is Corning's life sciences and emerging growth businesses — segment net sales?: Corning (GLW) reported life sciences and emerging growth businesses — segment net sales of $294M in Q2 2026.
What does life sciences and emerging growth businesses — segment net sales mean?: This metric represents the total revenue generated by the Life Sciences and Emerging Growth segment, which focuses on laboratory products and early-stage material science innovations. It reflects the market demand for Corning's specialized consumables and new technology platforms. Growth in this area indicates successful commercialization of new products and expansion in healthcare and high-tech markets.

Ask your AI about Corning's life sciences and emerging growth businesses — segment net sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk